AK0610 is engineered from an antibody isolated from a recovered infant and targets the pre-fusion F protein of RSV.

Knoxville, filed a bill Monday that would require Arkansas' Medicaid program to provide blood pressure monitors to pregnant women and postpartum women for up to one year after birth that are covered ...

Rumours that Donald Trump had chosen Martin Makary as FDA Commissioner have been confirmed, while the President-elect has ...

TUMBLING around on the floor with her big brother Oscar, happy three-year-old Aria Flynn is just like any other child her age ...

President-elect Donald Trump’s proposed lineup to lead the government’s health agencies look like bad news for vaccine ...

Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness, according to two studies published online Nov. 25 in Pediatrics.

Researchers estimate that 123,000 to 193,000 U.S. adults were hospitalized each year with respiratory syncytial virus in ...

A new RSV treatment has been cleared by the CDC and FDA and doctors are calling it a gamechanger for children. News4’s ...

"Flu tends to impact us a little later in the year, or early into the new year, so that at this point in time for any of the ...

Respiratory syncytial virus (RSV) is associated with a considerable burden of hospitalizations, intensive care unit (ICU) admissions, and in-hospital deaths among adults.

Moderna stock is undervalued with a $97 price target, strong COVID-19 revenue, promising pipeline, and long-term growth. Read ...

Amartya Mukhopadhyay's battery prototype is approximately 30 per cent cheaper than lithium-ion batteries, operates in a ...